Bio-Rad
For over six decades, Bio-Rad has served life science research and clinical diagnostics customers worldwide through its global network of operations. Bio-Rad is internationally renowned among academic institutions, pharmaceutical companies and major research institutions for its commitment to quality and customer service.
Latest Bio-Rad Content
Product
Advertisement
Anti-Idiotypic Antibodies
Bio-Rad is an expert manufacturer of highly specific, high affinity anti-idiotypic antibodies to support preclinical research, clinical trials and patient monitoring for innovator and biosimilar products.
Product
Advertisement
ZE5 Cell Analyzer
The ZE5 Cell Analyzer is an innovative flow cytometer with flexible configurations to meet a broad range of experimental complexities and throughput needs – accessible for novice flow cytometry users yet flexible enough for the most experienced flow cytometry professionals.
How To Guide
Perfect Your qPCR
Quantitative real-time PCR (qPCR) is a versatile technology, and widely used for applications such as clinical diagnostics, gene transcription analysis and agricultural breeding programs.
Product News
Bio-Rad Launches Annexin V StarBright Conjugates for Apoptosis Detection via Flow Cytometry
Annexin V Starbright™ conjugates offer increased choice and flexibility for apoptosis detection in conventional and full spectrum flow cytometry.
Product News
Bio-Rad’s Study Demonstrating Utility of Its SpyLock Technology for Fast Generation and Screening of Bispecific Antibodies
Study describes method to successfully modify the functional activity of Spycatcher protein for the rapid generation and high-throughput screening of bispecific antibodies.
Product News
Bio-Rad Adds Rapid Bispecific Antibody Prototyping and Screening Services To Pioneer Antibody Discovery Platform
New service enables identification of bispecific antibody candidates accelerating drug development.
Product News
Bio-Rad Outlines Its Advances Leveraging Droplet Digital PCR in Biopharma and Translational Research Sectors
Strategic collaborations in molecular residual disease monitoring of cancer and product launches in ddPCR portfolio advance corporate strategy in H1 2024.
App Note / Case Study
Rapid Detection of Mutations Using ddPCR
This application note showcases a Droplet Digital PCR (ddPCR) workflow that can detect mutations commonly associated with non-small-cell lung cancer (NSCLC) in a single-well, 6-plex reaction.
App Note / Case Study
Measure Allele Frequency for Genomic Reference Materials With ddPCR
This application note demonstrates the concordance of these technologies for variant calling.
eBook
Achieve Excellence in Your qPCR Experiments
This eBook explores the expanding role of qPCR across various industries and emphasizes the increasing demand for innovative qPCR platforms that meet modern research and diagnostic requirements.
Advertisement
